The Association of Real-World CA 19-9 Level Monitoring Patterns and Clinical Outcomes Among Patients With Metastatic Pancreatic Ductal Adenocarcinoma

by Ben George, Matthew Kent, Andy Surinach, Neil Lamarre, Paul Cockrum
Published 2021-10-01

Front‐line treatment patterns in multiple myeloma: An analysis of U.S.‐based electronic health records from 2011 to 2019

by Shaji Kumar, Mellissa Williamson, Uzor Ogbu, Andy Surinach, Stella Arndorfer, Wan‐Jen Hong
Published 2021-09-01

Reducing nihilism in metastatic pancreatic ductal adenocarcinoma: Treatment, sequencing, and effects on survival outcomes

by Eileen M. O'Reilly, Paul Cockrum, Andy Surinach, Zheng Wu, Allison Dillon, Kenneth H. Yu
Published 2020-11-01

Comparing real-world evidence among patients with metastatic pancreatic ductal adenocarcinoma treated with liposomal irinotecan

by Jim Koeller, Andy Surinach, Steven R. Arikian, Marko Zivkovic, Patrick Janeczko, Paul Cockrum, George Kim
Published 2020-08-01

Survival outcomes in an older US population with advanced melanoma and central nervous system metastases: SEER‐Medicare analysis

by Natalia Sadetsky, Alexandra Hernandez, Chris J. Wallick, Edward F. McKenna, Andy Surinach, Dawn E. Colburn
Published 2020-09-01

Real-world treatment patterns and adverse events in metastatic renal cell carcinoma from a large US claims database

by Sumanta Pal, Jun Gong, Shivani K. Mhatre, Shih-Wen Lin, Andy Surinach, Sarika Ogale, Rini Vohra, Herschel Wallen, Daniel George
Published 2019-06-01

Use of Patient Health Records to Quantify Drug-Related Pro-arrhythmic Risk

by Mark R. Davies, Michael Martinec, Robert Walls, Roman Schwarz, Gary R. Mirams, Ken Wang, Guido Steiner, Andy Surinach, Carlos Flores, Thierry Lavé, Thomas Singer, Liudmila Polonchuk
Published 2020-08-01